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Abstract
Introduction: It has been reported that the prognosis of optic perineuritis may be poor when initiation of
treatment is delayed. Here we report the successful treatment of three patients with idiopathic optic perineuritis,
including two in whom initiation of therapy was delayed.
Case presentation: Three Japanese patients (two women aged 73 and 66 years, and one man aged 27 years)
presented with loss of vision (for five months, several months, and two months respectively) and pain on eye
movement in the third case only, and were diagnosed as having idiopathic optic perineuritis. Fat-suppressed T2-
weighted magnetic resonance images showed high signal intensity areas around the affected optic nerves,
suggesting the presence of optic perineuritis. Two patients received steroid pulse therapy and the third was given
high-dose steroid therapy. The visual acuity improved in all three cases.
Conclusion: High-dose steroid therapy may be effective for idiopathic perineuritis in patients without optic nerve
atrophy, even if initial treatment (including moderate-dose steroids) has failed.
Introduction
Idiopathic optic perineuritis has been reported as a type
of orbital inflammatory pseudotumor [1-3]. Currently,
the diagnosis of optic perineuritis is most commonly
based on magnetic resonance image (MRI) findings
along with the clinical characteristics. Although some
reported cases have been diagnosed by pathologic exam-
inations, the distinction between optic neuritis and optic
perineuritis is generally radiographic [4]. The character-
istic differences between idiopathic optic perineuritis
and idiopathic optic neuritis are as follows [5]: The age
distribution of the former is wide and it particularly
affects elderly patients, and a paracentral scotoma or an
arcuate defect are frequent findings. The onset is slow
(usually over several weeks), and recovery is often poor
in patients with optic perineuritis when treatment is
delayed. The response to corticosteroids is often dra-
matic, although recurrence is common with tapering of
therapy. Here, we report the successful treatment of
three patients with idiopathic optic perineuritis who
received high-dose steroid therapy.
Case presentations
Case 1
A 73-year-old Japanese woman had noticed a decrease in
vision in her right eye for five months. On examination,
the visual acuity on her right side was 20/60. She was trea-
ted with prednisolone at doses of up to 30 mg/day for eye-
lid swelling. After five months, however, her acuity was
only 20/400 on her right side. A right relative afferent
pupillary defect was present. Goldmann perimetry showed
an arcuate scotoma of her right eye. Laboratory tests
revealed a CRP of 0.9 mg/dl (normal range: 0.0-0.3) and
an ESR of 38 mm/hour, while ACE, FTA, and ANCA
were all within the normal range. The results of hematol-
ogy tests, renal and liver function tests, urine analysis,
chest radiography, and computed tomography were all
within normal limits. Fat-suppressed T2-weighted MR
images revealed a high signal intensity area around her
right optic nerve and moderate swelling of her right
extraocular muscles, suggesting inflammation of her optic
nerve sheaths and extraocular muscles (Figure 1). Steroid
pulse therapy was initiated. After four days, the vision of
her right eye improved to 20/80. One month after steroid
pulse therapy, fat-suppressed T1-weighted MR images
showed persistence of the high signal intensity area around
her right optic nerve and moderate swelling of her right
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dose was gradually tapered. There has been no recurrence
of symptoms after an observation period of 22 months.
Case 2
A 66-year-old Japanese woman presented to our hospital
with decreased vision in her right eye that had persisted
for several months. Vision was 20/300 on her right side
and a relative afferent pupillary defect was detected,
although there were no abnormal intraocular findings.
Goldmann perimetry showed an arcuate scotoma of her
right eye. Laboratory tests revealed a CRP of 0.3 mg/dl,
while the ESR, ACE, FTA, and ANCA were all within
the normal range. The results of hematology tests, renal
and liver function tests, urine analysis, chest radiogra-
phy, and computed tomography were all within normal
limits. MR images showed high-intensity areas in her
right optic nerve sheath on fat-suppressed T2-weighted
images and fat-suppressed T1-weighted images (Figure 2);
these findings suggesting inflammation of her optic nerve
sheath. Treatment with prednisolone (40 mg/day) was
initiated. Subsequently, the steroid dose was gradually
tapered. After two months, there was a recurrence of
symptoms in her right eye, so prednisolone (40 mg/day)
was started again. Subsequently, the steroid dose was
tapered more gradually and her vision was 20/20 on the
right side after 11 months. Recurrence of symptoms has
not been detected after follow-up for 19 months.
Case 3
A 27-year-old Japanese man came to our hospital with
blurred vision in the upper field of his left eye and ocu-
lar pain/headache associated with eye movement that
had persisted for two months. His visual acuity was 20/
300 on his left side. There was swelling and erythema of
his left optic disc. Goldmann perimetry showed enlarge-
ment of Mariotte’s blind spot and a paracentral scotoma
of his left eye. Laboratory tests revealed a CRP of
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all within the normal range. The results of hematology
tests, renal and liver function tests, urine analysis, chest
radiography, and computed tomography were all within
normal limits. MR images revealed no abnormalities in
his brain. On fat-suppressed T2-weighted images, the
area around his left optic nerve showed a high intensity
(Figure 3). Steroid pulse therapy was initiated. After
Figure 1 Fat-suppressed T2-weighted MR images of Case 1. Coronal image (a) and axial image (b) from a 73-year-old Japanese woman with
idiopathic optic perineuritis. There is a high signal intensity area around the right optic nerve and moderate swelling of the right extraocular muscles,
suggesting inflammation around the optic nerve sheath and the extraocular muscles. Fat-suppressed T1-weighted magnetic resonance image
obtained one month after steroid pulse therapy. This axial image (c) shows persistence of the high signal intensity area around the right optic nerve
and moderate swelling of the right extraocular muscles. The extraocular muscles showed persistent moderate swelling (not visible on this image).
Figure 2 Fat-suppressed T2-weighted images of Case 2. Coronal image (a) and axial image (b) from a 66-year-old Japanese woman show
high-intensity areas in the right optic nerve sheath. Fat-suppressed T1-weighted post-contrast coronal image (c) shows high-intensity areas in
the right optic nerve sheath. The optic nerve sheath is enlarged and enhanced on both sides.
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Subsequently, the dose of steroids was gradually
reduced. No recurrence has been noted after 15 months.
Discussion
The prognosis of optic perineuritis has been reported to
be poor when initiation of treatment is delayed [5].
However, our first two cases both responded well to
s t e r o i dt h e r a p ya n da c h i e v e d a good visual prognosis,
despite the interval between the onset of symptoms and
initiation of treatment being longer than six months.
Concerning the steroid dose, recurrence was observed in
Case 2 after treatment with prednisolone at a daily dose
of 40 mg in the early stage of her illness, and Case 1
showed recurrence after receiving prednisolone at a
dose of 30 mg/day at her previous hospital. After we
performed steroid pulse therapy at our hospital for
Cases 1 and 3, there was no recurrence in Case 3, and
no subsequent recurrence in Case 1. Purvin et al.
reported recurrence of optic perineuritis in 4 out of 14
patients treated with oral steroids at doses of 60-80 mg/
day [5].
Perimetry was performed up to isopter I-1e in all of
our patients. The innermost isopter of the central visual
field that showed a response was isopter I-4e in Case 1,
i s o p t e rI - 2 ei nC a s e2 ,a n di s o p t e rI - 1 ei nC a s e3 .T h u s ,
C a s e s1a n d2d i dn o tr e s p o n dt oi s o p t e rI - 1 e ,s u g g e s t -
ing the presence of central depression. Perimetry of the
peripheral visual fields including the paracentral field
revealed arcuate constriction on the downside of isopter
V-4e in Case 1, who showed a generalized decrease of
sensitivity. In Case 2, depression was seen on the upside
of Mariotte’s blind spot in isopter I-4e, indicating a
paracentral scotoma. In Case 3, scotomata were
observed at three sites on the upside of Mariotte’sb l i n d
spot in isopter III-4e. These results suggest that reduced
vision was at least partly ascribable to a decrease of cen-
tral visual field sensitivity in Cases 1 and 2, whereas
vision was reduced despite the lack of a central scotoma
or reduction of central field sensitivity in Case 3. There-
fore, the reduced visual acuity was related to central or
generalized depression of vision due to optic perineuritis
in Cases 1 and 2. In Case 3, vision may have been
reduced because scotomata involved the fixation point.
This case series had the following limitation. The best
diagnostic sequence for optic perineuritis is post-con-
trast fat-suppressed T1-weighted images. On other
images, the area of hyperintensity around the optic
nerve could represent an increase of cerebrospinal fluid
that would occur if there was optic atrophy. However,
we did not obtain fat-suppressed T1-weighted images in
all three cases, although such images are required for
the definite diagnosis of optic perineuritis.
Conclusions
Two patients with optic perineuritis who underwent
steroid pulse therapy showed no recurrence, as did one
patient receiving high-dose prednisolone. Our results
suggest that steroid pulse therapy or high-dose predni-
solone may be effective for idiopathic optic perineuritis
in patients without optic nerve atrophy, even if initial
treatment (including moderate-dose steroids) has failed.
Consent
Written informed consent was obtained from the
patients for publication of this case series and any
accompanying images. Copies of the written consents
are available for review by the Editor-in-Chief of this
journal.
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